VTVT
VTVT
NASDAQ · Biotechnology

Vtv Therapeutics Inc- Cl A

$40.53
+0.87 (+2.19%)
As of Apr 1, 10:08 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -17.2% upside
Low Target $24.17
Average Target $33.56
High Target $46.23
Current Price $40.53
Current
$40.53
Target
$33.56
$24.17 $33.56 avg $46.23
Scenario Analysis
Bear Case
$24.17
-40.4%
Low target
Base Case
$33.56
-17.2%
Avg target
Bull Case
$46.23
+14.1%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$44.00
-7.9% from high
52-Week Low
$14.00
+189.5% from low
Target vs 52W High
$33.56
-23.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%